Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.30
-0.2600-0.37%
Volume:251.64K
Turnover:17.86M
Market Cap:5.87B
PE:-115.25
High:72.68
Open:71.15
Low:69.85
Close:70.56
52wk High:90.87
52wk Low:49.38
Shares:83.46M
Float Shares:77.19M
Volume Ratio:1.13
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6100
EPS(LYR):7.78
ROE:-7740.12%
ROA:2.46%
PB:-35.48
PE(LYR):9.04

Loading ...

PTC Therapeutics director Alethia Young resigns from board

Reuters
·
Jun 10

PTC Therapeutics Shares Rise After Upgrade From Citigroup

MT Newswires Live
·
Jun 10

PTC Therapeutics Coverage Assumed by Citigroup at Buy vs Previous Rating of Neutral

Dow Jones
·
Jun 09

Citigroup Upgrades PTC Therapeutics to Buy From Hold, Raise Price Target to $108 From $76

MT Newswires Live
·
Jun 09

PTC Therapeutics Inc : Citigroup Assumes Coverage With Buy VS Neutral Rating; Price Target $108 VS $75

THOMSON REUTERS
·
Jun 09

PTC Therapeutics assumed with Buy from Neutral at Citi

TIPRANKS
·
Jun 09

A Look At PTC Therapeutics (PTCT) Valuation As Models Flag A Potential Discount

Simply Wall St.
·
Jun 06

PTC Therapeutics Shareholders Back Board, Pay and Auditor

TIPRANKS
·
Jun 06

PTC Therapeutics Raised to Buy From Hold by Jefferies

Dow Jones
·
May 28

PTC Therapeutics Inc : Jefferies Raises to Buy From Hold; Raises Target Price to $85 From $76

THOMSON REUTERS
·
May 27

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes 2,812 shares for $202,817.36

Reuters
·
May 20

PTC Therapeutics CEO Makes Head-Turning Insider Stock Move

TIPRANKS
·
May 16

PTC Therapeutics EVP, CLO Mark Elliott Boulding disposes 3,540 shares for $279,257.20

Reuters
·
May 13

PTC Therapeutics publishes corporate presentation on Sephience launch, 2026 guidance

Reuters
·
May 11

PTC Therapeutics (PTCT) Gets a Hold from Citi

TIPRANKS
·
May 10

PTC Therapeutics’ Earnings Call Highlights Sephience Surge

TIPRANKS
·
May 09

PTC Therapeutics Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
May 09

Stock Track | PTC Therapeutics Soars 13.49% Intraday on Strong Q1 Earnings Beat, Raised Guidance and Analyst Upgrades

Stock Track
·
May 08

Morgan Stanley Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
May 08

TD Cowen Upgrades PTC Therapeutics to Buy From Hold, Adjusts Price Target to $90 From $75

MT Newswires Live
·
May 08